Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: J Pediatr. 2015 Dec 24;170:211–217.e2. doi: 10.1016/j.jpeds.2015.11.058

Table 1.

Biliary Atresia Outcomes by 2 Years of Age

Outcome Events Number (%) of Patients with Event Odds Ratio and 95 % CI for TB ≥ 2 vs TB < 2 mg/dL P-value
All BA (n=137) TB Status by 3 months after HPE
TB < 2 mg/dL (n = 68) TB ≥ 2 mg/dL (n = 69)
Weight z-Score <2.5 28 (20.4%) 8 (11.8%) 20 (29.0%) 3.1 (1.2, 7.5) 0.015
Height z-Score < −2.5 26 (18.9%) 10 (14.7%) 16 (23.2%) 1.8 (0.7, 4.2) 0.21
Midarm Circumference z-score < −2.5 51 (37.2%) 24 (35.3%) 27 (39.1%) 1.2 (0.6, 2.4) 0.64
Hypoalbuminemia (Albumin < 3.0 gr/dL) 46 (33.6%) 9 (13.2%) 37 (53.6%) 7.6 (3.2, 17.7) <0.0001
Coagulopathy (INR >1.5) 26 (19.0%) 3 (4.4%) 23 (33.3%) 10.8 (3.1, 38.2) 0.0002
Hyponatremia (Na < 130 mEq/L) 5 (3.7%) 1 (1.5%) 4 (5.8%) 4.1(0.4, 37.9) 0.21
Thrombocytopenia (Platelets < 150,000/μL) 65 (47.5%) 32 (47.1) 33 (47.8) 1.03 (0.5, 2.0) 0.93**
Splenomegaly 86 (62.8%) 48 (70.6) 38 (55.1) 0.5 (0.3, 1.03) 0.062
Ascites 52 (38.0%) 12 (17.7%) 40 (58.0%) 6.4 (2.9, 14.1) <0.0001
Variceal hemorrhage 9 (6.6%) 5 (7.4%) 4 (5.8%) 0.8 (0.2, 3.0) 0.71
Liver Transplant 57 (41.6%) 10 (14.7%) 47 (68.1%) 12.4 (5.3, 28.7) <0.0001
Death 9 (6.6%) 2 (2.9%) 7 (10.1%) 3.7 (0.7, 18.6) 0.11
Death or Liver Transplant 66 (48.2%) 12 (17.7%) 54 (78.3%) 16.8 (7.2, 39.2) <0.0001
*

Bold indicates P value < 0.05

**

Note by Kaplan-Meier analysis, thrombocytopenia was more common for TB>2 (Figure 1)